slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,645
Current window 8,041-8,070
Pages 355
Rows per page 30
Component
8,041-8,070 of 10,645
04
The slide uses a direct quote to frame the company's sales practices as unethical or problematic.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
05
The slide uses a testimonial to cast doubt on the company's reported metrics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes1 hit
20
The slide uses a direct quote from an earnings call to highlight a lack of transparency and potential business risk.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
38
The slide uses a combination of summary text and a direct testimonial quote to establish a pattern of behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
40
The slide uses a testimonial quote to support a narrative of corporate malfeasance and trial data manipulation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle1 hit
51
The slide uses a quote from a 2004 NEJM paper to establish a precedent of drug withdrawal, then links the molecular structure (piperidine ring) and receptor activity of pitolisant to these withdrawn drugs.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal1 hit
82
The slide uses a 'villain critique' style to undermine the target drug (pitolisant) by associating it with failed industry-wide efforts.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
96
The slide uses a Q&A format to discredit the competitor's R&D rigor.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
105
The slide uses a 'quote-and-critique' structure to expose potential data manipulation in clinical reporting.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
120
The slide uses a combination of narrative argument and a direct quote from a consultant to build a case against the company's transparency.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
121
The slide presents a direct quote from a PK expert to undermine the validity of the company's safety assertions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
130
The slide uses direct citations from FDA and research documents to highlight the discrepancy between single-dose study designs and the need for steady-state peak plasma concentration analysis.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
131
The slide uses a quote from a pharmacology consultant to argue that safety margins are overestimated due to drug accumulation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
140
The slide uses a quote from a consultant to challenge the validity of the company's (Harmony) data submitted to the FDA.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
158
The slide uses direct quotes from FDA clinical reviews to highlight the discrepancy between pre-approval assumptions and post-approval safety signals.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
204
The slide highlights a discrepancy between the drug's safety profile as presented and the real-world experience of a physician.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
21
Uses an ex-employee quote to frame the current CEO as a promoter rather than a technical leader.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Struggle to Overcome Technical Challenges1 hit
40
The slide uses a 'hero's journey' style progression of technology, but the footnotes reveal the images are not IonQ's own proprietary hardware.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Struggle to Overcome Technical ChallengesLoop · Aha Moment1 hit
45
Uses direct quotes from SEC filings to undermine company claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
46
The slide uses a 'CEO quote contradiction' framework to undermine management credibility.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
68
Uses a 'before-after' style contradiction between company marketing and reality.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
72
Uses direct quotes and screenshots from UMD and L3-Harris websites to establish the contradiction.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
90
Uses Q&A format to frame the critique as an expert interview.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
121
Uses a Q&A format to highlight operational reliability issues.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
122
The slide uses a direct quote from an internal paper to contradict the company's public narrative on scalability.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
128
The slide uses a direct expert quote to undermine the company's technical viability.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
155
The slide uses a combination of narrative accusation and direct quotes from earnings materials to build a case of financial misrepresentation.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
165
Uses a red arrow to connect the visual marketing material to the CEO's specific claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
172
The slide uses a 'villain' framing by questioning the capacity of the subject to fulfill all stated obligations.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit
176
The slide uses a highlight to emphasize the core contradiction in the quote.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 1 hit